Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Central Nervous System Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00098891
What this trial is testing

MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+41 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00219297
What this trial is testing

Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer

Who this might be right for
Brain MetastasisNon-small Cell Lung Cancer
Novartis Pharmaceuticals 50
Early research (Phase 1)Study completedNCT00036972
What this trial is testing

Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01051557
What this trial is testing

Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Diffuse Astrocytoma+6 more
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT00301873
What this trial is testing

Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma

Who this might be right for
Brain TumorsOsteoporosisCentral Nervous System(CNS)Malignancies
Duke University 60
Early research (Phase 1)Study completedNCT00005639
What this trial is testing

Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 34
Testing effectiveness (Phase 2)Study completedNCT00671970
What this trial is testing

Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)

Who this might be right for
GlioblastomaGliosarcoma
Duke University 57
Not applicableStudy completedNCT00595322
What this trial is testing

Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma

Who this might be right for
Brain CancerRecurrent Malignant GliomasPrimary Brain Tumor
Memorial Sloan Kettering Cancer Center 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT02114229
What this trial is testing

Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors

Who this might be right for
Malignant Rhabdoid TumorAtypical Teratoid Rhabdoid Tumor
St. Jude Children's Research Hospital 125
Testing effectiveness (Phase 2)Study completedNCT02312622
What this trial is testing

Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer

Who this might be right for
Stage IV Non-small Cell Lung Cancer (NSCLC)Recurrent Non-small Cell Lung Cancer (NSCLC)Extensive-stage Small Cell Lung Cancer (SCLC)+3 more
Joel Neal 27
Not applicableEnded earlyNCT00952185
What this trial is testing

Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more
City of Hope Medical Center 9
Early research (Phase 1)Enrolling By InvitationNCT06827782
What this trial is testing

Cord Blood-derived CAR-NK Cells Targeting CD19 for Refractory/Relapsed Central Nervous System Lymphoma

Who this might be right for
Refractory/Recurrent Central Nervous System Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 42
Early research (Phase 1)Study completedNCT00064779
What this trial is testing

Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+2 more
INSYS Therapeutics Inc 18
Testing effectiveness (Phase 2)Study completedNCT00980343
What this trial is testing

GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)Study completedNCT03925246
What this trial is testing

Efficacy of Nivolumab for Recurrent IDH Mutated High-Grade Gliomas

Who this might be right for
High Grade GliomaBrain Cancer
Assistance Publique - Hôpitaux de Paris 43
Early research (Phase 1)Study completedNCT02238496
What this trial is testing

Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas

Who this might be right for
Brain Tumor, RecurrentGlioblastomaAnaplastic Astrocytoma+2 more
Andrew B Lassman, MD 10
Early research (Phase 1)Ended earlyNCT00512460
What this trial is testing

RTA 744 Injection in Patients With Leptomeningeal Disease

Who this might be right for
Neoplastic MeningitisSolid TumorLymphoma+2 more
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT00004113
What this trial is testing

Temozolomide in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT02885324
What this trial is testing

Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaMalignant Brain Tumor+1 more
Indiana University 4
Testing effectiveness (Phase 2)Study completedNCT00014677
What this trial is testing

NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Neurocrine Biosciences
Next Page